| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | -0.2% |
| Cost of Revenue | $2.4M | +128.6% |
| Gross Profit | $153K | -89.9% |
| R&D Expense | $1.8M | +93.8% |
| SG&A Expense | $7.6M | +120.5% |
| Operating Income | -$22.9M | -539.0% |
| Pre-tax Income | -$18.5M | -401.7% |
| Income Tax | -$307K | -1715.8% |
| Net Income | -$18.2M | -390.8% |
| EPS (Basic) | -$26.69 | -94.4% |
| EPS (Diluted) | -$26.69 | -94.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | +461.7% |
| Accounts Receivable | $289K | +194.9% |
| Inventory | $2.3M | +6.7% |
| Current Assets | $7.3M | +118.3% |
| Total Assets | $41.1M | +1033.2% |
| Current Liabilities | $6.7M | +144.7% |
| Total Liabilities | $7.6M | +154.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.4M | -272.5% |
| Capital Expenditures | $60K | +1900.0% |
| Investing Cash Flow | $88K | +3033.3% |
| Financing Cash Flow | $12.8M | — |
| Free Cash Flow | -$9.4M | -274.4% |
| $33.5M |
| +5242.4% |